Centinel Spine is a medical device company focused exclusively on Total Disc Replacement (TDR). The company develops and sells motion-preserving spinal implants to treat degenerative disc disease as an alternative to spinal fusion surgery. Centinel's sole commercial offering is the prodisc platform, which includes cervical systems for the neck and lumbar systems for the lower back. These implants use a fixed-core design to preserve natural spinal movement and stability across single- and two-level procedures. Centinel sells implants to hospitals and ambulatory surgery centers, reaching customers through independent distributors in the U.S. and through direct sales forces and stocking distributors internationally. The company also supplies reusable surgical instrument sets to healthcare facilities to support procedures. Centinel's strategy focuses on expanding surgeon adoption through clinical training, increasing patient awareness, securing broader reimbursement coverage, and obtaining regulatory approvals for expanded clinical indications.